Cargando…
Methylphenidate for attention deficit hyperactivity disorder and drug relapse in criminal offenders with substance dependence: a 24-week randomized placebo-controlled trial
AIM: To test the efficacy and safety of osmotic release oral system (OROS) methylphenidate (MPH) in doses up to 180 mg/day to treat attention deficit hyperactivity disorder (ADHD) and prevent any drug relapse in individuals with a co-diagnosis of ADHD and amphetamine dependence. DESIGN: Randomized p...
Autores principales: | Konstenius, Maija, Jayaram-Lindström, Nitya, Guterstam, Joar, Beck, Olof, Philips, Björn, Franck, Johan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226329/ https://www.ncbi.nlm.nih.gov/pubmed/24118269 http://dx.doi.org/10.1111/add.12369 |
Ejemplares similares
-
Self-rated impulsivity in healthy individuals, substance use disorder and ADHD: psychometric properties of the Swedish Barratt impulsiveness scale
por: Khemiri, Lotfi, et al.
Publicado: (2021) -
Impulsive choice in individuals with comorbid amphetamine use disorder and attention deficit-hyperactivity disorder
por: Brynte, Christoffer, et al.
Publicado: (2023) -
Alcohol Dependence Associated with Increased Utilitarian Moral Judgment: A Case Control Study
por: Khemiri, Lotfi, et al.
Publicado: (2012) -
Effects of the monoamine stabilizer (-)OSU6162 on cognitive function in alcohol dependence
por: Khemiri, Lotfi, et al.
Publicado: (2019) -
Effects of amphetamine on the human brain opioid system – a positron emission
tomography study
por: Guterstam, Joar, et al.
Publicado: (2013)